advertisement
This site is a B2B information site for professional use - clinical diagnostics products listed are for
Research Use Only
unless otherwise stated.
Home
News
Show All
Assay Development
Clinical & Veterinary
Food & Beverage
Microbiome
Other
Pharmaceutical
Water
Suppliers
Events
Show All
Assay Development
Clinical & Veterinary
Food & Beverage
Microbiome
Other
Pharmaceutical
Water
Test Methods
Buyers Directory
Assay Development
Clinical & Veterinary
Food & Beverage
Microbiome
Other
Pharmaceutical
Water
Newsletter
advertisement
advertisement
advertisement
advertisement
Home
News
News by sector:
clinical
& Date: 2021/01
News : clinical, Jan 2021
View by sector:
Show all
Assay Development
Clinical & Veterinary
Food & Beverage
Microbiome
Other
Pharmaceutical
Water
Go
Synthetic Molecular Standards for SARS-CoV-2
Assay Development
QC Molecular Standards
SARS-CoV-2
29 Jan 2021
ATCC release 3 quantitative synthetic molecular constructs for SARS-CoV-2 assay development; eliminating the need to culture viruses in the laboratory, and are safe to use under BSL-1 conditions.
BinaxNOW Rapid Antigen Test Shows High Sensitivity on Culture-Positive Specimens
Cell Culture
SARS-CoV-2
28 Jan 2021
The CDC COVID-19 Response Team & Epidemic Intelligence Service has published an evaluation of the Abbott BinaxNOW COVID-19 Rapid Antigen Test Card. The test showed high-sensitivity on culture-positive specimens.
Rapid Test Ag 2019-nCov: Prevent COVID-19 from Spreading!
Lateral Flow Assays
SARS-CoV-2
25 Jan 2021
The rapid antigen test of ProGnosis Biotech shows high sensitivity and specificity, has a CE-Mark and is included in the list of approved COVID diagnostic tests by the European Commission, the German BfArM and the Italian Ministry of Health.
New CE-Marked Quantitative SARS-CoV-2 IgG Antibody Test
SARS-CoV-2
22 Jan 2021
Beckman Coulter has announced CE-marking for its quantitative SARS-CoV-2 IgG Antibody test. The assay is designed to detect antibodies to the spike protein of SARS CoV-2, which is the design of the vaccines on the market today.
New Automated Whole-Blood Pipetting Workstation to Help Detect Latent TB
Automation
Latent Tuberculosis Infection
Mycobacterium tuberculosis
22 Jan 2021
Tecan has launched the Fluent® Mix and Pierce Workstation to provide end-to-end automation for whole blood pipetting in clinical environments. This will optimize sample preparation for latent tuberculosis (TB) testing with the QuantiFERON-TB Gold Plus assay.
Italy, Japan & Brazil Show Confidence in SARS-CoV-2 Microfluidic Rapid Antigen Test
SARS-CoV-2
22 Jan 2021
LumiraDx's microfluidic point-of-care antigen test for SARS-CoV-2 is now available in over 30 countries, including US, Japan & Brazil. The test is designed for nasal or nasopharyngeal swab specimens and a turnaround time-to-result of 12 minutes.
Use Artificial Intelligence to Streamline Your Culture Plate Workflow With APAS Independence
Artifical Intelligence
Automation
Plate Screening
19 Jan 2021
Bringing AI based automation to microbiology labs, the APAS® Independence automatically reads, interprets and sorts microbiology culture plates, successfully identifying plates with no significant growth, significant growth and those needing further review. Use the Automation Justification Tool.
COPAN Automation Saves Costs and Increases Efficiency as Shown in Multicenter Study
Artifical Intelligence
Automation
Laboratory Automation
19 Jan 2021
Recent multicenter study examines laboratories of various size, location, patient mix and acuity demonstrating that implementation of COPAN automation results in cost savings and increased efficiency and productivity for the laboratory.
Special Focus on Artificial Intelligence and Automation
Alicyclobacillus
Artifical Intelligence
Automation
19 Jan 2021
This special focus on Artificial Intelligence and Automation brings you the latest Industry/Quality 4.0 technologies designed to make human-robot collaboration easy, to improve productivity and deliver cost-savings for your microbiology lab.
Panel of Recombinant Variants for COVID-19 Antigen Test Development & ValidationÂ
Assay Development
SARS-CoV-2
19 Jan 2021
Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants based on Brazil, South Africa and UK lineages. It is now critical to assess if antigen tests can detect these variants due to N-protein mutations.
Accelerated Computing & AI to Sequence DNA/RNA
Next Generation Sequencing (NGS)
19 Jan 2021
Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high-throughput sequencing system, PromethION.
Integra's Electronic Pipettes Make Your Lab Life Easier
Liquid Handling
Multichannel Pipettes
Pipettes
18 Jan 2021
It takes just minutes to find out about the intelligent features of the lightweight VIAFLO electronic pipette and VOYAGER adjustable tip spacing pipette by viewing INTEGRA's short video tutorials.
Perform Multiplex SARS-CoV-2 & Winter Virus Testing Using Saliva Specimen
SARS-CoV-2
15 Jan 2021
The Seegene Allplex™ multiplex assays for COVID-19 & winter viruses can now detect viral RNA directly from a saliva specimen. These new and improved Allplex tests are CE-marked and require no nucleic acid extraction step.
Nepal Uses CRISPR in COVID-19 Testing Strategy
CRISPR
SARS-CoV-2
14 Jan 2021
The Nepalese Government will begin using the CRISPR SARS-CoV-2 kit as part of its COVID-19 testing strategy after a generous donation from a non-profit organization established by the test kit manufacturer.
New All-in-One Test for COVID-19/Flu/RSV
Respiratory Syncytial Virus (RSV)
SARS-CoV-2
13 Jan 2021
TCA/GENETWORx has launched a RT-PCR test to detect COVID-19, RSV and Flu from just one sample. Patients or providers can be informed of the result faster via the Aura digital platform.
FDA Issues Alert on Mutated Variants Avoiding Detection in COVID-19 Testing
SARS-CoV-2
11 Jan 2021
The US FDA has issued an alert regarding SARS-CoV-2 viral mutation to health care providers and clinical laboratory staff. The alert identifies three tests, which have EUA, that might be imapcted by the variants in circulation.
COVID-19 Test Manufacturers Advance to Finals in XPRIZE Competition
SARS-CoV-2
11 Jan 2021
The $6 million XPRIZE Rapid Covid Testing prize, a competition to create newer, higher standards of COVID-19 testing to help society safely return to everyday activities has announced 20 finalists into the next stage, concluding in February 2021.
Rapid Identifier in Suspected Sepsis Cases Takes Just 30 Minutes for Result
Candida auris
Gram-negative bacteremia
MALDI-TOF
11 Jan 2021
Bruker has announced FDA clearance for its MBT Sepsityper Kit US IVD that enables rapid, specific detection of many cases of bacteremia-induced sepsis to assist infectious disease specialists in potentially life-saving decisions.
New Synthetic RNA Control for UK Variant Strain of SARS-CoV-2
QC Molecular Standards
SARS-CoV-2
05 Jan 2021
Mutations in the new variant of SARS-CoV-2 have made some S-gene PCR tests invalid. Twist Bioscience is now offering an RNA control for labs to check the validity of their RT-PCR tests. This new control adds to Twist Bioscience's range of SARS-CoV-2 reagents.
The Role of LIMS in Supporting ISO 17025 Accreditation (Whitepaper)
ISO 17025
LIMS
05 Jan 2021
Autoscribe Informatics' new white paper examines the role of LIMS in supporting ISO 17025 accreditation. The white paper explores how a LIMS can play a key role in achieving, maintaining, and benefiting from ISO 17025 accreditation.
EC Issues Rapid Antigen Test Guidelines
SARS-CoV-2
04 Jan 2021
The European Commission (EC) has put forward rules to ensure the uniform use, validation and recognition of rapid antigen tests in the EU and signed a contract with Abbott and Roche to provide 20 million rapid antigen test kits to member states
WESAIL COVID-19 Ag & Ab Tests Now Added to Lists of Approved Kits
Lateral Flow Assays
SARS-CoV-2
04 Jan 2021
Rapid COVID-19 Antigen and Antibody Test Kits from WESAIL have now been added to the list of approved kits by Ministero della Salute (the Health Department, Italy), Paul-Ehrlich-Institut and the European Commission.
Sino Biological Offers Collection of Recombinant Antigens for New Spike N501Y Mutation
Assay Development
Recombinant Proteins
01 Jan 2021
Sino Biological has produced a collection of recombinant antigens for new variants of SARS-CoV-2. The reagents can be used to evaluate the efficacy of antibodies and vaccination.
First
Previous
Jun 25
...
...
Feb 21
Jan 21
Dec 20
...
Feb 04
Next
Last
FILTER BY SECTOR
Assay Development
Clinical & Veterinary
Food & Beverage
Microbiome
Pharmaceutical
Water
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
Cherwell Launches Redipor® TwistLock Plates to Enhance Sample Security in Microbial EM
17 Jun 2025
Introducing NAT-MAT®: Fast and Precise Pyrogen Detection Using Digital PCR
17 Jun 2025
Your Trusted Source for Microbial QC Controls and Proficiency Testing
17 Jun 2025
Antimicrobial Resistance and the MRSA Crisis: A Silent Pandemic Demanding Urgent Global Action
16 Jun 2025
Automation Starts at the Source with MWE SampleSUITE™ and SIGMA Range
16 Jun 2025
IDEXX Water Introduces UV Viewer PLUS™
16 Jun 2025
The Future of QC is Now! And Merck is Paving the Way!
16 Jun 2025
bioMérieux Acquires Day Zero Diagnostics Solutions and Technologies
16 Jun 2025
MAS-100 Instruments Adapted for Growth Direct Cassette
16 Jun 2025
Visibly Simple Pathogen Testing – Scalable Workflows, Reliable Results
12 Jun 2025
MICROBIOLOGY EVENTS
Getting Equipped for the Future with the New MAS-100 Sirius® Microbial Air Sampler
1 Jul 2025
AI for Food Safety Professionals
8 Jul 2025
FEMS Micro
14 Jul 2025
Unmasking Endotoxins: A Sample Preparation Strategy to Overcome LER
15 Jul 2025
IAFP 2025
27 Jul 2025
ADLM 2025
27 Jul 2025
Food Safety Culture Workshop
9 Sep 2025
CPD accredited course: Level 3 HACCP & Food Safety
15 Sep 2025
Culture Eats HACCP for Breakfast (free)
On-demand Webinar
A3P International Congress 2025
7 Oct 2025
advertisement
advertisement
advertisement
advertisement
X
© 2001 - 2025 Rapid Test Methods Ltd. All rights reserved.